The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg)

Tafenoquine (TQ) is an 8-aminoquinoline anti-malarial being developed for malaria prophylaxis. It has been generally assumed that TQ, administered prophylactically, acts primarily on the developing exoerythrocytic stages of malaria parasites (causal prophylaxis), and that polymorphisms in metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dow, Geoffrey, Smith, Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438551/
https://www.ncbi.nlm.nih.gov/pubmed/28526056
http://dx.doi.org/10.1186/s12936-017-1862-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438551/
https://www.ncbi.nlm.nih.gov/pubmed/28526056
http://dx.doi.org/10.1186/s12936-017-1862-4

Ejemplares similares